ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.850
+0.290 (6.36%)
Jun 15, 2026, 4:00 PM EDT - Market closed
ENDRA Life Sciences Employees
As of December 31, 2025, ENDRA Life Sciences had 11 total employees, including 9 full-time and 2 part-time employees. The number of employees decreased by 5 or -31.25% compared to the previous year.
Employees
11
Change (1Y)
-5
Growth (1Y)
-31.25%
Revenue / Employee
n/a
Profits / Employee
-$663,865
Market Cap
6.02M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 11 | -5 | -31.25% | 9 | 2 |
| Dec 31, 2024 | 16 | -5 | -23.81% | 14 | 2 |
| Dec 31, 2023 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2022 | 21 | -1 | -4.55% | 21 | 0 |
| Dec 31, 2021 | 22 | 4 | 22.22% | 22 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Burning Rock Biotech | 667 |
| MDxHealth | 364 |
| Biodesix | 334 |
| XWELL | 280 |
| Exagen | 220 |
| Precipio | 71 |
| bioAffinity Technologies | 57 |
| Advanced Biomed | 31 |
NDRA News
- 4 weeks ago - Endra Life Sciences reports Q1 EPS ($1.09) vs. ($1.86) last year - TheFly
- 4 weeks ago - ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 4 weeks ago - ENDRA Life Sciences Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Endra Life Sciences reports multi-site validation of TAEUS Liver device - TheFly
- 4 weeks ago - ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility - Business Wire
- 4 weeks ago - ENDRA Life Sciences Inc trading halted, volatility trading pause - TheFly
- 4 weeks ago - ENDRA Life Sciences Inc trading resumes - TheFly
- 2 months ago - Endra Life Sciences reports Q4 EPS ($8.93) vs ($56.94) last year - TheFly